Navigation Links
New method assesses risks for heart failure patients
Date:7/30/2008

COLUMBUS, Ohio Data from 260 hospitals across the United States has led to the creation of a new method for physicians to more accurately determine the severity of heart failure in patients upon hospital admission, with a goal of reducing in-hospital mortality and more quickly identifying triage methods and treatment decisions. The model is discussed in the July 29 issue of the Journal of the American College of Cardiology.

"Heart failure patients experience high rates of hospital stays and poor outcomes," said Dr. William Abraham, director of cardiovascular medicine at Ohio State University Medical Center and primary author of the article. "By utilizing this model, we can more quickly identify patients at risk for in-hospital mortality who might benefit from more aggressive monitoring and intervention."

The model was developed as part of the OPTIMIZE-HF (Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure) study, which offered recommendations to improve treatment of congestive heart failure based on monitoring more than 48,000 patients.

Baseline information, treatment patterns and in-hospital outcomes were recorded for each patient upon admission. A model was then developed to identify significant predictors of in-hospital mortality, such as gender, medical history, vital signs at admittance, heart failure characteristics or history, laboratory data and admission medication.

Of the more than 48,000 patients admitted for heart failure, the in-hospital mortality rate was approximately four percent, providing an adequate number of events to evaluate predictors.

The patient characteristics most predictive of in-hospital mortality were admission creatinine levels, systolic blood pressure and patient age. Increased risk was also associated with conditions such as liver disease, past cerebrovascular issues, vascular disease and chronic obstructive pulmonary disease. Diabetes, gender and coronary artery disease were not significant predictors of mortality.

According to Abraham, while the model provides a reliable tool for clinicians, it reports in-hospital mortality only, and was not validated for post discharge outcomes. In addition, the mortality risk might have been influenced by other factors that were not measured, documented or included in the database. Therefore, the model can only be applied for patients in whom the variables were assessed.

"Despite numerous advances in the treatment of chronic heart failure, more work is needed to reduce the high risk of mortality for patients hospitalized for heart failure," said Abraham. "An essential next step is to study whether applying this risk prediction score will favorably impact patient care and clinical outcomes."


'/>"/>

Contact: Doug Flowers
Doug.Flowers@osumc.edu
614-293-3737
Ohio State University Medical Center
Source:Eurekalert

Related medicine news :

1. Stanford study highlights cost-effective method of lowering heart disease risks
2. Different method of evaluating the urinary tract system reduces radiation dose
3. Report on patients access to cancer drugs uses flawed methods to reached flawed conclusions
4. A classic method for modeling skin cancer is featured in Cold Spring Harbor Protocols
5. Researcher developing new method for hearing loss assessment
6. Medicare Prescription Drug Benefit, Nonprofit Hospitals, Ambulatory Surgery Centers, Statistical Methods, and Pay-For-Performance Highlighted In the Latest INQUIRY Journal
7. GPS-like technology helps pinpoint best methods for moving injured players
8. New Seminar Series from Activator Methods Teaches Doctors a Unique Approach to Improving Nations Chiropractic Care: Focus on the Patients
9. Less invasive lymph node biopsy method could spare thousands unnecessary operations
10. 454 Sequencing(TM): Science Paper Describes a Novel, Highly Efficient Method of Sequencing Ancient DNA; Sequences the Mitochondria of 10 Individual Mammoths to Prove It
11. Manchester researchers announce new methods of beating breast cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/26/2017)... ... April 26, 2017 , ... ... the adoption of e-prescribing as measured in Part D Medicare data. The dataset, ... to pharmacies, either using e-prescribing, faxes or paper. The PaPR (pronounced "paper") ...
(Date:4/26/2017)... ... 2017 , ... Infertility may be a result of an ... many women become pregnant upon treating their diagnosis. , To properly ... We can provide the necessary information to diagnose and treat your problem. ...
(Date:4/26/2017)... ... 26, 2017 , ... New SUPRO® XT55 Isolated Soy ... by helping beverage manufacturers more effectively manage protein costs. “Soy protein has always ... well as more stable pricing over time. Now it’s even more relevant as ...
(Date:4/25/2017)... ... April 25, 2017 , ... Splashtop Inc. , ... . This new addition to the Mirroring360 product family combines device screen mirroring ... Mirroring360 Pro enables educators, business professionals and individuals to stream or mirror app ...
(Date:4/25/2017)... (PRWEB) , ... April 25, 2017 , ... ... CEOs, CFOs and HR decision-makers are preparing for how his administration could impact ... will provide insight into what changes are most likely to make it through ...
Breaking Medicine News(10 mins):
(Date:4/19/2017)... 2017 Cardiology devices segment is anticipated to reach ... The Cardiology Devices segment is likely to create absolute $ ... 2018 over 2017. By the end of 2027, Cardiology Devices ... US$ 700 Mn, expanding at a CAGR of 18.4% over ... Asia Pacific reprocessed medical devices market in ...
(Date:4/19/2017)... , Tenn. and DALLAS , April ... EndoStim, Inc., announced that the first patients in ... the EndoStim device in the Lower Esophageal Sphincter Stimulation ... a minimally-invasive implantable device designed to provide long-term reflux ... neurostimulation. GERD affects nearly 65 million people ...
(Date:4/19/2017)... , April 19, 2017  Novartis today announced ... National Heart, Lung, and Blood Institute (NHLBI) of ... 58% of patients with treatment-naïve severe aplastic anemia ... treated with eltrombopag at the initiation of and ... study evaluated three sequential treatment groups, or cohorts. ...
Breaking Medicine Technology: